Form.Get started

Buyer guide · 8 min read · Reviewed by US-licensed clinicians

10 questions to ask any telehealth weight-loss platform before paying

Telehealth weight-loss is now a crowded category, and the quality range is enormous. These are the ten questions a careful adult should ask any platform — including Form — before handing over a card. Compounded GLP-1 is compounded under section 503A of the FD&C Act; compounded GLP-1 is NOT FDA-approved as a finished product, and that fact should be acknowledged plainly by anyone selling it.

The truthful version of this category looks like this: there are platforms doing careful, regulated work with licensed clinicians and verified 503A pharmacies, and there are platforms doing the opposite. The marketing on the outside often looks indistinguishable. The questions below are the ones that separate them.

1. Which specific 503A pharmacy is preparing the medication?

A real answer includes a pharmacy name, a city and state, and a verifiable state board of pharmacy license. If the answer is vague — “a network of partners,” “our compounding partners,” or simply silence — that is the answer. You are entitled to know which physical pharmacy is preparing something that will go into your body.

2. Is the prescribing clinician licensed in my state?

Telehealth practice is governed by the state where the patient is physically located, not the state where the platform is headquartered. The clinician issuing your prescription must hold an active license in your state, and you should be able to look that license up on the state medical or nursing board website. Platforms that cannot or will not confirm in-state licensure should be treated with extreme caution.

3. Is there an actual evaluation, or just a checkbox quiz?

A quiz is fine as an intake tool. A quiz alone is not an evaluation. Federal and state rules require a meaningful clinical assessment before a prescription is issued. Ask what the assessment includes, who reviews it, and whether there is a live or asynchronous communication step.

4. What is your cancellation policy?

Read the cancellation terms before you start, not after. Look for: how to cancel, when refunds are or are not available, whether you are locked into a multi-month prepayment, and what happens to any unused medication. Platforms that bury the cancellation flow are doing it on purpose.

5. How do I reach a clinician between visits if I have side effects?

GLP-1 therapy without ongoing access to a clinician is not a care plan. Ask whether there is a secure portal, an asynchronous message channel, a phone line, or some combination. Ask what the typical response time is. Ask whether the responder is a licensed clinician or a support agent.

6. What red-flag language does the marketing use?

Specific phrases to be wary of

Be cautious of any platform that:

  • Calls compounded semaglutide or tirzepatide an “FDA-approved weight loss medication.” Compounded preparations are not FDA-approved as finished products.
  • Describes their compounded product as “the same as” or “generic” for Wegovy, Ozempic, Mounjaro, or Zepbound. The molecules may be the same; the products are not.
  • Guarantees a specific number of pounds lost in a specific number of weeks. Any clinician who guarantees that is overselling.
  • Uses dramatic before-and-after imagery without disclosing that individuals may be actors or models, or that the images may be AI-generated.
  • Cannot or will not produce a copy of the boxed warning when asked.

7. Will my data be sold or shared with third parties for marketing?

Read the privacy policy. Health and lifestyle data has significant commercial value, and not every platform is conservative about it. Look for a clear HIPAA notice, a specific statement about data sales (the answer should be no), and a description of which third-party processors handle your information.

8. What happens if the clinician says no?

A platform that prescribes to nearly everyone who pays is not screening well. Ask what their typical declination criteria look like. Ask whether you are refunded if the clinician determines GLP-1 therapy is not appropriate. Ask whether they can refer you elsewhere if there is a better fit.

9. What is included in the price?

“Starting at” pricing is rarely the price you actually pay. Get the full picture: medication cost (with titration steps that may differ), clinician visits, shipping, support, sharps containers. Compare programs on total monthly cost over the first three months, which is when titration is most active.

10. What does a long-term plan look like?

GLP-1 therapy is not a 30-day intervention. Ask the platform what they recommend at month six, month twelve, and if you decide to step off. Ask whether they support maintenance dosing, lifestyle-only phases, or transitions. A platform whose business model only works if you keep paying forever may not be the right partner for a chronic-care decision.

How Form answers these

For transparency: our compounded preparations are dispensed by state-licensed 503A pharmacies. The prescribing clinicians are independent, US-licensed, and only treat patients in states where they hold an active license. There is a real clinical evaluation, a secure portal for between-visit messages, a clearly published cancellation policy, and clinicians who decline patients when the picture does not fit. We do not promise pounds-on-the-scale outcomes and we do not call our compounded preparations equivalent to branded finished products. Compounded preparations may support weight management for eligible adults under clinician supervision; nothing more is promised, and nothing less is true.

Curious if you qualify?

Our 60-second eligibility check is reviewed by a US-licensed clinician.

Get started

No doctor-patient relationship is formed by completing the eligibility quiz on this website. Form Healthtech Innovations LLC is a software platform, not a medical practice or pharmacy. Prescriptions are issued only after an online evaluation by an independent licensed clinician contracted through our medical group partner. Compounded medications are dispensed by state-licensed 503A pharmacies and are not FDA-approved as finished products.

Form is pre-launch and has not yet published its own patient-outcome data. Any efficacy figures for the drug class (for example, clinical-trial results for FDA-approved branded GLP-1 medications) refer to those branded products, not to compounded formulations, which have not been studied as finished products. When Form has its own results, we will publish them with the sample size and methodology attached. Individual results vary and depend on clinical appropriateness, adherence, and your clinician’s recommendations.